Your browser doesn't support javascript.
loading
Efficacy and safety of anagrelide as a first-line drug in cytoreductive treatment-naïve essential thrombocythemia patients in a real-world setting.
Ito, Tomoki; Hashimoto, Yoshinori; Tanaka, Yasuhiro; Nakaya, Aya; Fujita, Shinya; Satake, Atsushi; Nakanishi, Takahisa; Konishi, Akiko; Hotta, Masaaki; Yoshimura, Hideaki; Ishii, Kazuyoshi; Hashimoto, Akiko; Kondo, Toshinori; Omura, Hiromi; Shinzato, Isaku; Tanaka, Takayuki; Nomura, Shosaku.
Afiliação
  • Ito T; First Department of Internal Medicine, Kansai Medical University, Hirakata, Japan.
  • Hashimoto Y; Department of Hematology, Tottori Prefectural Central Hospital, Tottori, Japan.
  • Tanaka Y; Department of Hematology and Clinical Immunology, Kobe City Nishi-Kobe Medical Center, Kobe, Japan.
  • Nakaya A; First Department of Internal Medicine, Kansai Medical University, Hirakata, Japan.
  • Fujita S; First Department of Internal Medicine, Kansai Medical University, Hirakata, Japan.
  • Satake A; First Department of Internal Medicine, Kansai Medical University, Hirakata, Japan.
  • Nakanishi T; First Department of Internal Medicine, Kansai Medical University, Hirakata, Japan.
  • Konishi A; First Department of Internal Medicine, Kansai Medical University, Hirakata, Japan.
  • Hotta M; First Department of Internal Medicine, Kansai Medical University, Hirakata, Japan.
  • Yoshimura H; First Department of Internal Medicine, Kansai Medical University, Hirakata, Japan.
  • Ishii K; First Department of Internal Medicine, Kansai Medical University, Hirakata, Japan.
  • Hashimoto A; Department of Hematology and Clinical Immunology, Kobe City Nishi-Kobe Medical Center, Kobe, Japan.
  • Kondo T; Department of Hematology, Kawasaki Medical School, Kurashiki, Japan.
  • Omura H; Department of Hematology, Tottori Prefectural Central Hospital, Tottori, Japan.
  • Shinzato I; Department of Hematology and Clinical Immunology, Kobe City Nishi-Kobe Medical Center, Kobe, Japan.
  • Tanaka T; Department of Hematology, Tottori Prefectural Central Hospital, Tottori, Japan.
  • Nomura S; First Department of Internal Medicine, Kansai Medical University, Hirakata, Japan.
Eur J Haematol ; 103(2): 116-123, 2019 Aug.
Article em En | MEDLINE | ID: mdl-31107982
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinazolinas / Inibidores da Agregação Plaquetária / Trombocitemia Essencial Tipo de estudo: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Haematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Japão País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinazolinas / Inibidores da Agregação Plaquetária / Trombocitemia Essencial Tipo de estudo: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Haematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Japão País de publicação: Reino Unido